Current advances and future perspectives in extrusion-based bioprinting

Ibrahim T. Ozbolat, Monika Hospodiuk

Research output: Contribution to journalReview article

322 Citations (Scopus)

Abstract

Extrusion-based bioprinting (EBB) is a rapidly growing technology that has made substantial progress during the last decade. It has great versatility in printing various biologics, including cells, tissues, tissue constructs, organ modules and microfluidic devices, in applications from basic research and pharmaceutics to clinics. Despite the great benefits and flexibility in printing a wide range of bioinks, including tissue spheroids, tissue strands, cell pellets, decellularized matrix components, micro-carriers and cell-laden hydrogels, the technology currently faces several limitations and challenges. These include impediments to organ fabrication, the limited resolution of printed features, the need for advanced bioprinting solutions to transition the technology bench to bedside, the necessity of new bioink development for rapid, safe and sustainable delivery of cells in a biomimetically organized microenvironment, and regulatory concerns to transform the technology into a product. This paper, presenting a first-time comprehensive review of EBB, discusses the current advancements in EBB technology and highlights future directions to transform the technology to generate viable end products for tissue engineering and regenerative medicine.

Original languageEnglish (US)
Pages (from-to)321-343
Number of pages23
JournalBiomaterials
Volume76
DOIs
StatePublished - Jan 1 2016

Fingerprint

Bioprinting
Extrusion
Technology
Tissue
Printing
Lab-On-A-Chip Devices
Hydrogels
Regenerative Medicine
Tissue Engineering
Biological Products
Tissue engineering
Microfluidics
Fabrication

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

@article{4d20d6a269c84c7192cf8684407ce491,
title = "Current advances and future perspectives in extrusion-based bioprinting",
abstract = "Extrusion-based bioprinting (EBB) is a rapidly growing technology that has made substantial progress during the last decade. It has great versatility in printing various biologics, including cells, tissues, tissue constructs, organ modules and microfluidic devices, in applications from basic research and pharmaceutics to clinics. Despite the great benefits and flexibility in printing a wide range of bioinks, including tissue spheroids, tissue strands, cell pellets, decellularized matrix components, micro-carriers and cell-laden hydrogels, the technology currently faces several limitations and challenges. These include impediments to organ fabrication, the limited resolution of printed features, the need for advanced bioprinting solutions to transition the technology bench to bedside, the necessity of new bioink development for rapid, safe and sustainable delivery of cells in a biomimetically organized microenvironment, and regulatory concerns to transform the technology into a product. This paper, presenting a first-time comprehensive review of EBB, discusses the current advancements in EBB technology and highlights future directions to transform the technology to generate viable end products for tissue engineering and regenerative medicine.",
author = "Ozbolat, {Ibrahim T.} and Monika Hospodiuk",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.biomaterials.2015.10.076",
language = "English (US)",
volume = "76",
pages = "321--343",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

Current advances and future perspectives in extrusion-based bioprinting. / Ozbolat, Ibrahim T.; Hospodiuk, Monika.

In: Biomaterials, Vol. 76, 01.01.2016, p. 321-343.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current advances and future perspectives in extrusion-based bioprinting

AU - Ozbolat, Ibrahim T.

AU - Hospodiuk, Monika

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Extrusion-based bioprinting (EBB) is a rapidly growing technology that has made substantial progress during the last decade. It has great versatility in printing various biologics, including cells, tissues, tissue constructs, organ modules and microfluidic devices, in applications from basic research and pharmaceutics to clinics. Despite the great benefits and flexibility in printing a wide range of bioinks, including tissue spheroids, tissue strands, cell pellets, decellularized matrix components, micro-carriers and cell-laden hydrogels, the technology currently faces several limitations and challenges. These include impediments to organ fabrication, the limited resolution of printed features, the need for advanced bioprinting solutions to transition the technology bench to bedside, the necessity of new bioink development for rapid, safe and sustainable delivery of cells in a biomimetically organized microenvironment, and regulatory concerns to transform the technology into a product. This paper, presenting a first-time comprehensive review of EBB, discusses the current advancements in EBB technology and highlights future directions to transform the technology to generate viable end products for tissue engineering and regenerative medicine.

AB - Extrusion-based bioprinting (EBB) is a rapidly growing technology that has made substantial progress during the last decade. It has great versatility in printing various biologics, including cells, tissues, tissue constructs, organ modules and microfluidic devices, in applications from basic research and pharmaceutics to clinics. Despite the great benefits and flexibility in printing a wide range of bioinks, including tissue spheroids, tissue strands, cell pellets, decellularized matrix components, micro-carriers and cell-laden hydrogels, the technology currently faces several limitations and challenges. These include impediments to organ fabrication, the limited resolution of printed features, the need for advanced bioprinting solutions to transition the technology bench to bedside, the necessity of new bioink development for rapid, safe and sustainable delivery of cells in a biomimetically organized microenvironment, and regulatory concerns to transform the technology into a product. This paper, presenting a first-time comprehensive review of EBB, discusses the current advancements in EBB technology and highlights future directions to transform the technology to generate viable end products for tissue engineering and regenerative medicine.

UR - http://www.scopus.com/inward/record.url?scp=84961219034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961219034&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2015.10.076

DO - 10.1016/j.biomaterials.2015.10.076

M3 - Review article

C2 - 26561931

AN - SCOPUS:84961219034

VL - 76

SP - 321

EP - 343

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -